Literature DB >> 31134502

The Heterogeneity of Osteosarcoma: The Role Played by Cancer Stem Cells.

Kristina Schiavone1, Delphine Garnier2, Marie-Francoise Heymann2, Dominique Heymann3,4.   

Abstract

Osteosarcoma is the most common bone sarcoma and is one of the cancer entities characterized by the highest level of heterogeneity in humans. This heterogeneity takes place not only at the macroscopic and microscopic levels, with heterogeneous micro-environmental components, but also at the genomic, transcriptomic and epigenetic levels. Recent investigations have revealed the existence in osteosarcoma of cancer cells with stemness properties. Cancer stem cells are characterized by their specific phenotype and low cycling capacity, and are linked to drug resistance, tumour growth and the metastatic process. In addition, cancer stem cells contribute to the enrichment of tumour heterogeneity. The present manuscript will describe the main characteristic features of cancer stem cells in osteosarcoma and will discuss their impact on maintaining tumour heterogeneity. Their clinical implications will also be briefly addressed.

Entities:  

Keywords:  Cancer stem cell; Cancer stem-like cells; Cell dormancy; Circulating tumour cells; Clinical trials; Drug resistance; Gene mutation drivers; Monitoring; Osteosarcoma; Tumour heterogeneity

Mesh:

Year:  2019        PMID: 31134502     DOI: 10.1007/978-3-030-14366-4_11

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  17 in total

Review 1.  Immune Microenvironment in Osteosarcoma: Components, Therapeutic Strategies and Clinical Applications.

Authors:  Tianyi Zhu; Jing Han; Liu Yang; Zhengdong Cai; Wei Sun; Yingqi Hua; Jing Xu
Journal:  Front Immunol       Date:  2022-06-01       Impact factor: 8.786

2.  Osteosarcoma Cell-Derived Exosomal ELFN1-AS1 Mediates Macrophage M2 Polarization via Sponging miR-138-5p and miR-1291 to Promote the Tumorgenesis of Osteosarcoma.

Authors:  Bangmin Wang; Xin Wang; Po Li; Xiaoying Niu; Xiaoxiao Liang; Guancong Liu; Zhiyong Liu; Hong Ge
Journal:  Front Oncol       Date:  2022-06-17       Impact factor: 5.738

3.  Untargeted LC-MS/MS analysis reveals metabolomics feature of osteosarcoma stem cell response to methotrexate.

Authors:  Feng Wang; Zhiyu Zhang; Qin Li; Tao Yu; Chengbin Ma
Journal:  Cancer Cell Int       Date:  2020-06-24       Impact factor: 5.722

4.  Global disease score (GDS) is the name of the game!

Authors:  Poul F Høilund-Carlsen; Lars Edenbrandt; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-06-10       Impact factor: 9.236

5.  Ganoderma lucidum Exerts an Anticancer Effect on Human Osteosarcoma Cells via Suppressing the Wnt/β-Catenin Signaling Pathway.

Authors:  Qi-Hao Zhang; Qin-Xiao Hu; Da Xie; Bo Chang; Hou-Guang Miao; Yun-Guo Wang; De-Zhong Liu; Xue-Dong Li
Journal:  Integr Cancer Ther       Date:  2019 Jan-Dec       Impact factor: 3.279

Review 6.  Sarcoma treatment in the era of molecular medicine.

Authors:  Thomas Gp Grünewald; Marta Alonso; Sofia Avnet; Ana Banito; Stefan Burdach; Florencia Cidre-Aranaz; Gemma Di Pompo; Martin Distel; Heathcliff Dorado-Garcia; Javier Garcia-Castro; Laura González-González; Agamemnon E Grigoriadis; Merve Kasan; Christian Koelsche; Manuela Krumbholz; Fernando Lecanda; Silvia Lemma; Dario L Longo; Claudia Madrigal-Esquivel; Álvaro Morales-Molina; Julian Musa; Shunya Ohmura; Benjamin Ory; Miguel Pereira-Silva; Francesca Perut; Rene Rodriguez; Carolin Seeling; Nada Al Shaaili; Shabnam Shaabani; Kristina Shiavone; Snehadri Sinha; Eleni M Tomazou; Marcel Trautmann; Maria Vela; Yvonne Mh Versleijen-Jonkers; Julia Visgauss; Marta Zalacain; Sebastian J Schober; Andrej Lissat; William R English; Nicola Baldini; Dominique Heymann
Journal:  EMBO Mol Med       Date:  2020-10-13       Impact factor: 12.137

7.  Identification and Verification of Immune-Related Gene Prognostic Signature Based on ssGSEA for Osteosarcoma.

Authors:  Bo Xiao; Liyan Liu; Aoyu Li; Cheng Xiang; Pingxiao Wang; Hui Li; Tao Xiao
Journal:  Front Oncol       Date:  2020-12-15       Impact factor: 6.244

8.  Development of a Nomogram for Predicting the Efficacy of Preoperative Chemotherapy in Osteosarcoma.

Authors:  Qingshan Huang; Chenglong Chen; Jingbing Lou; Yi Huang; Tingting Ren; Wei Guo
Journal:  Int J Gen Med       Date:  2021-08-26

9.  SOX2 Expression and Transcriptional Activity Identifies a Subpopulation of Cancer Stem Cells in Sarcoma with Prognostic Implications.

Authors:  Sofia T Menendez; Veronica Rey; Lucia Martinez-Cruzado; M Victoria Gonzalez; Alvaro Morales-Molina; Laura Santos; Verónica Blanco; Carlos Alvarez; Oscar Estupiñan; Eva Allonca; Juan Pablo Rodrigo; Javier García-Castro; Juana Maria Garcia-Pedrero; Rene Rodriguez
Journal:  Cancers (Basel)       Date:  2020-04-13       Impact factor: 6.639

10.  The Na+/K+ ATPase Inhibitor Ouabain Attenuates Stemness and Chemoresistance of Osteosarcoma Cells.

Authors:  Weixiong Guo; Bo Wei; Tingting Cheng; Xiaotao Xu; Feiling Ruan; Min Xiang
Journal:  Med Sci Monit       Date:  2019-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.